The global burden of asthma

Area of Science:

• Pulmonology
• Public Health
• Epidemiology

Background:

• Global asthma prevalence, morbidity, and mortality have significantly increased over the past 40 years, disproportionately affecting children.
• Approximately 300 million individuals worldwide have asthma, with a concerning 50% increase in prevalence each decade.
• Despite advancements like inhaled corticosteroids, asthma remains underdiagnosed and undertreated, leading to increased hospital admissions and economic burden.

Purpose of the Study:

• To highlight the escalating global burden of asthma, including its prevalence, morbidity, mortality, and economic impact.
• To identify key challenges in asthma management, such as underdiagnosis, undertreatment, and barriers to care, particularly in developing nations.
• To present the Global Initiative for Asthma's management plan as a strategy to improve patient outcomes in primary care settings.

Main Methods:

• This study is a review and synthesis of existing data on asthma prevalence, trends, and management.
• Analysis of global epidemiological data, healthcare utilization, and economic impact of asthma.
• Examination of current asthma management guidelines and patient care strategies.

Main Results:

• Worldwide, asthma affects 300 million people, with prevalence increasing by 50% per decade.
• An estimated 180,000 asthma-related deaths occur annually, with most preventable and occurring in individuals over 45.
• The economic burden ranges from $300 to $1,300 per patient annually, with significant disparities in access to care and medication.

Conclusions:

• The rising global burden of asthma necessitates improved diagnosis, treatment, and patient education.
• Addressing barriers to care, especially in developing countries, is critical for reducing asthma-related morbidity and mortality.
• The Global Initiative for Asthma's six-point management plan offers a framework for effective primary care of asthma patients.